REDWOOD CITY, Calif.--(BUSINESS WIRE)--PROCEPT BioRobotics Corporation, a surgical robotics company developing intelligent solutions to transform the field of urology, has announced that the safety ...
Medicare Part B covers Aquablation for BPH if a person meets specific eligibility criteria, including a prostate volume of 30 to 150 cubic centimeters (cc). Medicare does not cover Aquablation in ...
REDWOOD CITY, Calif., Feb. 14, 2022 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transformative ...
REDWOOD SHORES, Calif.--(BUSINESS WIRE)--PROCEPT® BioRobotics, a Silicon Valley surgical robotics company, announced today that the American Urological Association (AUA) has amended its surgical ...
Benign Prostatic Hyperplasia (BPH), or enlarged prostate, is a common condition affecting millions of men, especially those over 50. It can lead to uncomfortable urinary symptoms and significantly ...
SAN JOSE, Calif., May 06, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics (PRCT) ® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing ...
SAN JOSE, Calif., July 14, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company dedicated to advancing patient care through ...
G_enlarged prostate_BPH Randomized trial reveals no significant difference between Aquablation and TURP in improvements in lower urinary tract symptoms, peak urinary flow, and post-void residual ...
SAN JOSE, Calif., June 17, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics ® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing ...
REDWOOD CITY, Calif., Sept. 28, 2021 (GLOBE NEWSWIRE) -- PROCEPT® BioRobotics Corporation (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transformative ...
CHI Memorial announces it is the first in the Chattanooga region to offer Aquablation therapy for the treatment of lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH), or ...
BofA Securities recently downgraded PROCEPT BioRobotics from Buy to Neutral, citing slowing utilization growth and moderating system sales for its Aquablation technology amid tighter hospital capital ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback